Tom Williams

16PUBLICATIONS
65CO-AUTHORS
Molecular medicineGene and molecular therapySpeech pathologyCentral nervous systemMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 13, 2026
Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled trial.

|Jun 29, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

|Nov 27, 2025
The ABILHAND-23 Patient Reported Outcome Measure in Secondary Progressive Multiple Sclerosis: A Cross-Sectional Analysis With the Nine Hole Peg Test.

Sean Apap Mangion, Charles Wade, Tom Williams

|Jul 09, 2025
Executive Dysfunction and Disability in SPMS: Predictive Value of the Frontal Assessment Battery in the UCLH MS-STAT2 Cohort.

Charles Wade, Anisha Doshi, Sean Apap Mangion

|Dec 18, 2024
Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosis.

Nevin A John, Yingtong Li, Floriana De Angelis

|Jul 22, 2024
Investigating cortical hypoxia in multiple sclerosis via time-domain near-infrared spectroscopy.

Thomas Williams, Frédéric Lange, Kenneth J Smith

Pageof 3

Frequent Collaborators

4 joint publications

Charles Wade

3 joint publications

Sean Apap Mangion

3 joint publications

Nevin John

3 joint publications

Jeremy Chataway